Usually not. Bupa's By You guide excludes weight-loss treatment even when it is needed for medical reasons, AXA Health's handbook names drug treatment in its weight-loss exclusion, and a weekly pen you collect and use at home also meets the take-home drug rules some insurers print. Vitality's guide stands out for surgery, with a part-paid benefit for gastric operations, but that is an operation, not a jab, and the answer on any policy rests on its own wording. If you are choosing cover with one of these treatments in mind, the form on this page wants only a few contact details, nothing clinical. An FCA-authorised broker then phones to show you how the options on your quote word it, with no charge for the call.
Jab, tablet or operation: which one are you asking about?
"Weight-loss treatment" covers three quite different things, and an insurer's wording usually treats them differently.
- Injections. Mounjaro is a brand of tirzepatide. The NHS describes it as a medicine for type 2 diabetes or obesity that is "only available with a prescription, either NHS or private" (NHS, Tirzepatide, page last reviewed 15 May 2026). It comes as a once-weekly injection.
- Wegovy, Ozempic and Rybelsus. These are brands of semaglutide. The NHS says semaglutide is used to treat obesity (called Wegovy) or manage type 2 diabetes (called Ozempic and Rybelsus) (NHS, Semaglutide, page last reviewed 15 May 2026). The same drug can therefore be prescribed for two different reasons, and that matters when you ask whether a policy pays.
- Surgery. The NHS calls weight-loss surgery "sometimes called bariatric surgery" and describes it as surgery that makes your stomach smaller (NHS, Overweight and obesity in adults, page last reviewed 29 April 2026).
Every phrasing people search, from "does health insurance cover Ozempic" to "which private health insurance covers Wegovy", comes down to the same two checks. First, does the policy pay for a medicine you collect and take home? Second, does it treat weight loss as an excluded purpose whatever the medical reason? The next sections take them in turn.
Does Bupa cover Mounjaro or weight-loss jabs?
Bupa is the insurer most searchers name, so it is the one worth reading closely. Its By You policy guide has a numbered exclusion headed "Cosmetic, reconstructive or weight loss treatment". The clause opens: "Treatment isn't covered even if it's needed for medical or psychological reasons, if it:" and then lists four conditions. One of them is: "involves weight-loss, surgery such as bariatric surgery" (Bupa By You policy guide, BINS 14718, guide for policies starting after 1 May 2024, page 30, read 29 October 2026).
Two things follow from the wording rather than from guesswork. A medical or psychological reason does not rescue a treatment that falls inside the clause, so "my doctor recommends it" is not the test. And bariatric surgery is named, so a reader asking about a gastric band or bypass has a direct answer for that guide. No medicine is named, but the heading says weight loss treatment rather than weight-loss surgery, and surgery appears only as the example, so a jab is not obviously outside it. Bupa applies the clause to each claim, and the guide is a general document for all By You policies, not your own certificate.
The injection question has a second route in the same guide. A separate exclusion, number 14 on page 31, says drugs or dressings "provided or prescribed for outpatient treatment or for you to take home" are not covered, apart from the cancer-drug exception it sets out. A weekly pen collected from a pharmacy is a take-home prescription, which is the situation that exclusion describes. The full set of drug clauses across insurers sits on our page on whether private health insurance covers medication, and Bupa's exclusions as a whole are covered in the Bupa exclusions list.
Whether your own Bupa policy has any different terms is shown on your membership certificate and in any special conditions, not in the general guide. If you already hold a Bupa policy and are unsure, the broker who phones after you submit the form can help you work out what to look for in those papers.
Other insurers: AXA, Aviva, Vitality and the rest
Searchers also ask about AXA Health, Aviva and Vitality by name. Each has its own wording, and they do not all say the same thing.
AXA Health is the most direct about jabs. Its Personal Health membership handbook says: "We do not cover any weight loss treatment, regardless of why it is needed. This includes drug treatment, surgery and procedures such as the fitting of a gastric band, creation of a gastric sleeve, or other similar treatments." (AXA Health, Personal Health membership handbook, October 2024, section 4.44, page 31; hosted by an intermediary at crm.more-health.co.uk.) The Exeter's one-page summary of its Health+ policy lists bariatric surgery, and weight-loss surgery or treatment generally, among what it does not insure (Insurance Product Information Document, MKTG770, June 2026, page 1), and that is a summary rather than the full policy.
Aviva's Healthier Solutions terms have a clause headed weight loss surgery, which excludes treatment linked, directly or indirectly, to bariatric surgery such as gastric banding or a gastric bypass, or the removal of surplus or fat tissue (Aviva policy terms, print reference AV1590050_GEN6842_0326, page 26; check the terms sent with your quote). That heading is about operations; how Aviva would treat a prescription for a jab is one to raise when a broker rings you, a call you can arrange using this page's form at no cost.
Vitality goes the other way for surgery. Its Membership Guide (VHTCR0002 08/2024, hosted by a broker at mytribeinsurance.co.uk, pages 17 and 18) describes a weight loss surgery benefit for gastric banding, a gastric bypass or a gastric sleeve that pays 75% of an agreed treatment package. The conditions are strict: you must be 18 or over, have been on the plan for at least three years, have a BMI of 35 or more with at least one listed condition such as type 2 diabetes or hypertension, have made a concerted attempt to lose weight by non-surgical means in the three years before your first consultation, and have the procedure authorised in advance. The benefit covers those three operations, not medicines. The comparison by insurer, with the clauses quoted, is on our page on surgery cover for operations and on the medication page above for drugs.
Weight-loss surgery and the NHS test it is measured against
The NHS publishes its own eligibility test for the operation. It says you may be offered surgery if you have a BMI of 40 or over, or a BMI of 35 or over with other health conditions that could be improved by weight loss, such as type 2 diabetes or high blood pressure. For people from a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background, it gives lower BMI figures: 37.5 or over, or between 32.5 and 37.4 with such a condition (NHS, Overweight and obesity in adults, page last reviewed 29 April 2026).
That is the NHS's rule for the NHS, not a rule any insurer applies. Where a policy has a weight-loss surgery benefit, its own eligibility terms apply, and where the policy excludes it, the NHS criteria do not change that. This page cannot tell you what a decision would be on your own case, and it is not medical advice; a GP is the person to ask about whether treatment is suitable.
Paying for a jab yourself, and the NHS route first
If your policy will not pay, the options are an NHS route or a private prescription. The NHS says a GP can refer you for weight management programmes, medicines or surgery, and that "depending on your BMI, and if you have any other health conditions affected by your weight, you may be able to have medicines to help you lose weight" (NHS, Overweight and obesity in adults, page last reviewed 29 April 2026). For tirzepatide it adds that you will usually only be prescribed it for weight loss if your BMI meets the eligibility criteria, and that those criteria depend on whether you get it through your doctor or a specialist weight management service.
On the private side, the NHS warns: "If you decide to get a private prescription for tirzepatide, it's important to buy it from a registered pharmacy. There are some websites that sell fake weight loss medicines." The NHS semaglutide page gives the same warning for Wegovy.
Reading that as a shopper: an NHS prescription route and a private one are separate doors, and an insurance policy is a third that may stay shut. Knowing which door you are standing at, before you pay a premium on the strength of a hoped-for refund, is the most useful thing to settle first. If the answer on your policy is no, the money for a pen and the appointments around it comes from you, and a reader on a tight budget is better placed knowing that now than after the first invoice.
The price of a private prescription varies by pharmacy, dose and date, so compare a few registered pharmacies before you commit. Whatever you pay is a cash cost that sits outside the policy; keep it apart from any premium you are quoted.
What the NHS says these medicines do, and why the stated purpose matters
The NHS describes tirzepatide as a dual agonist that "activates the gut hormone receptors GLP-1 and GIP", and says it works for weight loss by reducing appetite and helping you feel fuller for longer (NHS, Tirzepatide, page last reviewed 15 May 2026). Its obesity page groups semaglutide, tirzepatide and liraglutide as appetite-reducing medicines, and adds orlistat, which stops the body absorbing as much fat from food. Weight loss medicines are usually prescribed alongside diet and lifestyle advice, and after stopping you should be offered support to stay a healthy weight (NHS, Overweight and obesity in adults, page last reviewed 29 April 2026).
For an insurance question the point is the sequence of events. A weight-loss prescription is a series of repeat supplies, collected and taken at home, alongside lifestyle support, rather than a single episode of hospital treatment. Bupa's guide, like AXA Health's handbook, separates drugs given as part of hospital treatment from drugs you take home, which is why the take-home drug clause and the weight-loss exclusion can both bear on the same prescription.
When the same drug is prescribed for diabetes
Because tirzepatide and semaglutide are also diabetes medicines, a prescription for one of them can be for a long-term condition rather than for weight. Bupa's guide, for example, says "Treatment of chronic conditions isn't covered", and counts a condition as chronic if it has at least one of a list of features, among them needing ongoing or long-term control or relief of symptoms, or having no known cure (exclusion 6, page 28). So the reason on the prescription may change which clause is relevant. Which side of that line a particular policy puts it on is something the policy says in terms, and there is a fuller explanation of how pre-existing and long-term conditions are handled on our page on pre-existing conditions.
Five wording checks if weight loss is on your mind
If weight-loss treatment is part of why you are comparing cover, these checks tend to settle it, roughly in this order:
- Does this policy exclude weight-loss treatment by name, and does the exclusion apply "even if it's needed for medical or psychological reasons"?
- Is a take-home prescription, such as a weekly pen, covered anywhere, or is every drug you collect excluded?
- Is there a weight-loss surgery benefit, and what eligibility tests does it set?
- If I am already taking one of these medicines, how will it be treated at application, and does that change the underwriting route?
- What does my membership certificate or any special condition add to the general guide?
A broker can set out what several insurers say on each of those points on the call that follows your form. Only name, age band, phone number, email and postcode go into the form itself; your medicines and history are for the conversation.
Weight-loss jabs and health insurance: your questions
Does Ozempic count as a weight-loss injection for insurance?
Ozempic is the semaglutide brand the NHS lists for managing type 2 diabetes, while Wegovy is the brand it lists for obesity. How an insurer treats a prescription depends on its wording and the reason given, so name the exact medicine and the reason when you ask.
Can Bupa prescribe Mounjaro?
A prescription is written by a doctor, not by an insurer, and the NHS says tirzepatide is available only on prescription, NHS or private. Whether Bupa pays toward the cost is a separate question, answered by the exclusions above and by your own certificate.
Can I get Mounjaro or Wegovy on the NHS?
Sometimes. The NHS says you may be able to have weight loss medicines depending on your BMI and any other health conditions affected by your weight, and that a GP can advise and refer you. The eligibility criteria for tirzepatide differ between a doctor and a specialist weight management service.
What is the difference between Mounjaro and Wegovy?
They are different medicines. Mounjaro is tirzepatide, which activates two gut hormone receptors, GLP-1 and GIP; Wegovy is semaglutide, the brand the NHS names for obesity. Both are prescription-only, and if you get a private prescription the NHS advises buying from a registered pharmacy, because some websites sell fake weight loss medicines.
Will health insurance pay for a gastric band?
Usually not: Bupa's and Aviva's wordings exclude bariatric surgery, and AXA Health's names the fitting of a gastric band. Vitality's guide is the exception described above, paying 75% of an agreed package for members who meet its conditions, including three years on the plan.
Is there a policy that covers GLP-1 drugs?
AXA Health's handbook names drug treatment in its weight-loss exclusion, and Bupa's guide excludes weight-loss treatment as well as take-home drugs. For any other policy, the broker who rings once you have sent the form can check with you how it treats these medicines, at no cost.